Potential Benefits of AOD-9604 AOD-9604 1
Although GLP-1 medications have complex dosing schedules, you can consider switching between GLP-1 medications if you experience intolerable side effects with your current medication, do not get significant results, or due to a drug shortage
Research applications Amylin receptor agonism and binding-kinetics assays Satiety and appetite-signalling pathway research Gastric motility and emptying mechanism modelling Energy homeostasis and body-weight pathway investigation Combination studies alongside GLP-1 agonists such as semaglutide Specifications Form: Lyophilised powder Purity: 99% (HPLC verified) Storage: 20C, protected from light and moisture Available sizes: 5mg 10mg Certificate of Analysis: available on request External Reference Research literature
Enhanced expressions of Wnt5a/JNK signaling pathway-related molecules in the lung tissues of asthmatic rats
Ongoing Monitoring: Noom Med providers monitor patients through app-based reporting and monthly check-ins
(2023) Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial